About Quantumcyte
Quantumcyte is a company based in Sunnyvale (United States) founded in 2013 by Bidhan Chaudhuri and John Butler.. Quantumcyte has raised $1.3 million across 2 funding rounds from investors including IndieBio. Quantumcyte offers products and services including QCPRECISE™ Platform and Sample Processing Service. Quantumcyte operates in a competitive market with competitors including Reaction Biology, ImmunoSCAPE, Kiyatec, Cellply and PhenoVista, among others.
- Headquarter Sunnyvale, United States
- Founders Bidhan Chaudhuri, John Butler
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.3 M (USD)
in 2 rounds
-
Latest Funding Round
$1.05 M (USD), Seed
Aug 15, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Quantumcyte
Quantumcyte offers a comprehensive portfolio of products and services, including QCPRECISE™ Platform and Sample Processing Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Increases nucleic acid purity from biopsies for reliable multi-omic applications.
Handles tissue samples to deliver purified DNA or RNA for genomics.
Unlock access to complete
Unlock access to complete
Funding Insights of Quantumcyte
Quantumcyte has successfully raised a total of $1.3M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.05 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $1.1M
-
First Round
First Round
(31 May 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Seed - Quantumcyte | Valuation |
investors |
|
| May, 2017 | Amount | Seed - Quantumcyte | Valuation | IndieBio |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Quantumcyte
Quantumcyte has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Quantumcyte
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Quantumcyte
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Quantumcyte Comparisons
Competitors of Quantumcyte
Quantumcyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Reaction Biology, ImmunoSCAPE, Kiyatec, Cellply and PhenoVista, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
|
|
| domain | founded_year | HQ Location |
High-dimensional immune profiling services are delivered via proprietary platform.
|
|
| domain | founded_year | HQ Location |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| domain | founded_year | HQ Location |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| domain | founded_year | HQ Location |
A CRO that provides phenotypic assay development and screening services.
|
|
| domain | founded_year | HQ Location |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Quantumcyte
When was Quantumcyte founded?
Quantumcyte was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Where is Quantumcyte located?
Quantumcyte is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Who is the current CEO of Quantumcyte?
John Butler is the current CEO of Quantumcyte. They have also founded this company.
Is Quantumcyte a funded company?
Quantumcyte is a funded company, having raised a total of $1.3M across 2 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on May 31, 2017.
What does Quantumcyte do?
Quantumcyte was founded in 2013 and is headquartered in Sunnyvale, United States. Operations are centered in the biotechnology sector, where drug assay systems for cancer treatment are developed. These systems support evaluation of therapeutic compounds in research settings. The company is led by co-founders John Butler as CEO and Bidhan Chaudhuri as CTO. Focus remains on advancing assay technologies for oncology applications within the U.S. market.
Who are the top competitors of Quantumcyte?
Quantumcyte's top competitors include ImmunoSCAPE, CytoTronics and Kiyatec.
What products or services does Quantumcyte offer?
Quantumcyte offers QCPRECISE™ Platform and Sample Processing Service.
Who are Quantumcyte's investors?
Quantumcyte has 1 investor. Key investors include IndieBio.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.